Table 6.
Comparison of anthropometric, Glycemic, Lipid profile, and Neuro‐cognitive factors pre‐ and post‐AOL advance meditation with Decreased Po2 (n = 15)
| Parameters | M | M | t‐value | CI (95%) | p value | |
|---|---|---|---|---|---|---|
| Minimum | Maximum | |||||
| Weight | 73.93 ± 13.35 | 74.40 ± 12.30 | −0.822 | −1.68 | 0.75 | .425 |
| BMI | 26.13 ± 3.58 | 26.40 ± 3.27 | −1.740 | −0.60 | 0.06 | .104 |
| Waist | 94.93 ± 8.47 | 94.00 ± 7.82 | 0.989 | −1.09 | 2.96 | .339 |
| HIP | 104.20 ± 7.17 | 103.73 ± 7.25 | 0.507 | −1.51 | 2.44 | .620 |
| Systolic | 133.60 ± 18.90 | 136.60 ± 18.07 | −0.930 | −9.92 | 3.92 | .368 |
| Diastolic | 90.60 ± 12.45 | 91.93 ± 9.40 | −0.520 | −6.83 | 4.17 | .611 |
| PO2 | 91.53 ± 3.20 | 89.402.95 | 3.702 | 0.90 | 3.37 | .002 |
| Pulse Rate | 88.80 ± 13.89 | 87.20 ± 12.34 | 0.419 | −6.59 | 9.79 | .682 |
| Glucose | 71.87 ± 3.76 | 74.73 ± 4.45 | −3.267 | −4.75 | −0.98 | .006 |
| Cholesterol | 208.73 ± 37.89 | 202.27 ± 35.09 | 2.719 | 1.37 | 11.57 | .017 |
| Triglycerides | 220.80 ± 161.23 | 214.20 ± 159.6 | 1.812 | −1.21 | 14.41 | .092 |
| HDL | 39.40 ± 2.75 | 39.60 ± 3.18 | −0.408 | −1.25 | 0.85 | .689 |
| LDL | 124.80 ± 17.41 | 120.07 ± 14.81 | 2.424 | 0.54 | 8.92 | .029 |
| CDL/HDL | 5.43 ± 1.16 | 5.00 ± 1.04 | 3.122 | 0.13 | 0.73 | .008 |
| LDL/HDL | 3.29 ± 0.61 | 3.07 ± 0.47 | 1.385 | −0.12 | 0.55 | .189 |
| VLDL | 44.00 ± 32.30 | 42.67 ± 31.97 | 1.784 | −0.27 | 2.94 | .096 |
| HB | 15.73 ± 1.91 | 15.60 ± 1.76 | 0.807 | −0.22 | 0.49 | .433 |
| STAI | 36.47 ± 7.64 | 27.33 ± 6.41 | 5.423 | 5.52 | 12.75 | .000 |
| MWB | 57.47 ± 6.32 | 61.00 ± 9.20 | −1.610 | −8.24 | 1.17 | .130 |
| OHQ | 129.33 ± 13.32 | 147.47 ± 20.70 | −3.950 | −27.98 | −8.29 | .001 |
| SLCT | 28.20 ± 8. | 32.73 ± 8.75 | −2.105 | −9.15 | 0.09 | .054 |
Bold represent statistically significant change after advanced meditation protocol.